PPT-First Responder Naloxone Grant Webinar

October 24 th 2016 Sarah Ruiz MSW Naloxone Pilot Program Massachusetts Department of Public Health Alexander Walley MD MSc Medical Director MDPH Opioid Overdose Prevention Pilot Program. 1 1 1 1 2 ? 2 ? 3 longer than the rebid suit also forcing... responder must bid at least one more time. One of the first things you were taught about bridge biddin Emergency Medical Responders and. Law Enforcement. There may be a title here that come from the foundation. Objectives . In this slide set, you will learn:. What naloxone (. Narcan. ) is. How it works when administered to a person who has overdosed. for Peace Officers and EMTs . Objectives . Background & statutes . Define naloxone . Routes of administration . Training requirements . Immunity . The Opioid Problem: . Lethal Drug. overdose. is the leading cause of . Public Concern. Public Expectation. “All the Other Kids Are Doing It”. 256.40(3)(b). Opioid. Antagonists. A law enforcement officer or fire fighter who, reasonably believing another person to be undergoing an . Catherine Borella Chemistry BA Class of 2016. Senior Chemistry Seminar . University of New Hampshire, Durham, NH, USA. Discussions. How the Government is Mandating Naloxone. Monte-Carlo (MC) Simulation Approach . Intranasal Administration of Naloxone for Suspected Opiate Overdose. Objectives. Overview of the problem . HB 965. What is an Opiate. Abuse. Side effects. Overdose indicators. What is Naloxone (. Narcan. Los Angeles County EMS Agency. Special Thanks for the Development of this Program. UCLA Center for Prehospital Care. Los Angeles EMS Agency Curriculum Committee. This . training . program. meets the regulatory . Objectives . Background & statutes . Define naloxone . Routes of administration . Training requirements . Immunity . The Opioid Problem: . Lethal Drug. overdose. is the leading cause of . accidental death in America . Rebecca McDonald. National Addiction . Centre. King’s College London. Declarations. RM has undertaken an unpaid student industry placement with . Mundipharma. Research Ltd., with focus on the analysis of naloxone nasal spray formulations. . Please read the consent agreement in front of you and further instructions will be given on how to complete the pre-training survey. . . Remove . the “ID” number label and save it . – you’ll need this for today’s post-training survey, . Findings from a linked dataset. Dan Galanis, Ph.D.. Epidemiologist. EMS & Injury Prevention System Branch. Hawaii Department of Health. 2. Overview of presentation. Part 1: EMS administration of naloxone (2012-2016). Promoting Overdose Prevention and Naloxone Icebreaker Name Where you are from How much experience do you have giving community presentations? Your favorite topic for a presentation, your least favorite topic (that you have been asked to do, in public) First Responder Naloxone Grant FY18 Webinar Sarah Ruiz, Program Director Dr. Alex Walley, Medical Director Brittni Reilly, Program Coordinator Monday 9/25/2017 Audio:   1-877-838-7060 Agenda Review of Current Statistics / Trends NALOXONE (. Narcan. ®). Developed in the 1960s. Increased opioid use and abuse. Greater . variety of available opioids . Increased demand for naloxone. Opioid . competitive antagonist. Emergent overdose treatment in hospital and .